HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: ard.2005.040766v1 65/3/312    most recent Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beeharry, D Articles by Durrington, P N Search for Related Content PubMed PubMed Citation Articles by Beeharry, D Articles by Durrington, P N

Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis

¹ University of Manchester Division of Cardiovascular and Endocrine Science, Department of Medicine and Department of Clinical Biochemistry, Manchester Royal Infirmary, Oxford Road, Manchester M13, UK
² Department of Orthopaedics, Addenbrooke’s Hospital, Hills Road, Cambridge, UK

Correspondence to:
Correspondence to:
Professor P N Durrington
University of Manchester Division of Cardiovascular and Endocrine Science, Department of Medicine and Department of Clinical Biochemistry, Manchester Royal Infirmary, Oxford Road, Manchester M13, UK; pdurrington{at}manchester.ac.uk

Background: Patients with heterozygous familial hypercholesterolaemia (HeFH) develop tendon xanthomata (TX), most commonly in their Achilles tendons. Even before tendons are chronically enlarged, tenosynovitis may occur and medical advice be sought. Untreated HeFH carries a high risk of premature coronary heart disease, which can be ameliorated by early diagnosis.

Objective: To determine the prevalence of episodes of Achilles tendon pain in HeFH before its diagnosis.

Methods: Patients with definite HeFH (Simon Broome criteria) attending a lipid clinic were identified. They completed a questionnaire asking about symptoms relating to their Achilles tendons. Unaffected spouses or cohabiting partners served as controls.

Results: 133 patients (47% men) and 87 controls (51% men) participated. TX had been recognised by the referring physicians in <5% of cases. However, 62 (46.6% (95% confidence interval (CI) 38.1 to 55.1)) patients had experienced one or more episodes of pain in one or both Achilles tendons lasting >3 days, whereas only 6 (6.9% (1.6 to 12.2)) controls had done so (difference p<0.001; likelihood ratio 6.75). Typically, in the patients with HeFH the pain lasted 4 days (median). It was described as severe or very severe in 24/62 (38.7% (30.4 to 47.0)) patients with HeFH, but never more than moderate in controls. 35 (26.3% (18.8 to 33.8)) patients with HeFH had consulted a doctor about Achilles tendon pain, but in no case had this led to a diagnosis of HeFH. None of the controls had consulted a doctor.

Conclusions: Measurement of serum cholesterol in patients presenting with painful Achilles tendon could lead to early diagnosis of HeFH.

Keywords: Achilles tenosynovitis; cholesterol; familial hypercholesterolaemia; tendon xanthomata

This article has been cited by other articles:

				D Beeharry, B Coupe, E W Benbow, J Morgan, S Kwok, V Charlton-Menys, M France, and P N Durrington Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis Heart, September 1, 2006; 92(9): 1277 - 1277. [Full Text] [PDF]

				H. Marcovitch What's new this month in BMJ Journals BMJ, April 15, 2006; 332(7546): 904 - 904. [Full Text] [PDF]

eLetters: